Table 1.
Characteristics | PFCs (n = 12) | PPC (n = 2) | WON (n = 10) |
---|---|---|---|
Type of LAMS, n (%) | |||
DMHS | 7 (58.3) | 1 (50.0) | 6 (60.0) |
AXIOS | 5 (41.7) | 1 (50.0) | 4 (40.0) |
Total No. of endoscopic reinterventions | |||
0 | 9 | 3 | 6 |
1 | 1 | 0 | 1 |
>1 | 2 | 0 | 2 |
Cyst irrigation, n (%) | 1 (8.3) | 0 | 1 (8.3) |
Technical success, n (%) | |||
YES | 12 (100) | 2 (100) | 10 (100) |
Clinical success, n (%) | |||
YES | 10 (83.3) | 2 (100) | 8 (80.0) |
NO | 2 (16.7) | 0 | 2 (20.0) |
Adverse events, n (%) | |||
Infection | 6 (50) | 1 (50) | 5 (50) |
Bleeding | 0 | 0 | 0 |
Stent migration | 1 (8.3) | 0 | 1 (10.0) |
Stent occlusion | 1 (8.3) | 0 | 1 (10.0) |
Duration of procedure, min (mean ± SD) | 65.6 ± 24.3 | 51.5 ± 23.3 | 68.4 ± 24.7 |
Hospital stay, days (mean ± SD) | 17.1 ± 8.6 | 16.5 ± 3.5 | 17.2 ± 9.4 |
Days to stent removal, days (range) | 29.6 (18–45) | 27.5 (27–28]) | 30.1 (18–45) |
LAMS: lumen-apposing metal stents; PFCs: pancreatic fluid collections; PPC: pancreatic pseudocysts; WON: walled-off necrosis; SD: standard deviation.